ArticleBMC medical research methodology2025
Inclusive methodological awareness for equity and diversity in biomedical research.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since publishing its first study, the Special Collection: Inclusive Methodological Awareness for Equity and Diversity has engaged a diverse audience in critically examining the broader question of equity and diversity in healthcare and biomedical research, notably the challenges and opportunities that shape this issue. A common thread that continued to crystallize was that achieving equity and diversity does not necessarily require new or groundbreaking methodologies but, instead, a deliberate, conscientious approach to planning, conducting, evaluating, and reporting research to ensure meaningful representation and a deeper understanding of the population(s) involved. This understanding was echoed in ongoing debates about how ethnic and racial categories are constructed, particularly in how clinical trials and causal inference research engage with these elements to understand and address disparities. It also extends to the discussions surrounding the design and implementation of more inclusive clinical trials, thus emphasizing the importance of recruitment and retention of historically underserved racial and ethnic minorities, as well as other socioeconomically disadvantaged groups. The work described in this collection further highlights the imperative of co-creating complex public health and healthcare interventions in partnership with affected communities. In this editorial, we reflect on these insights and notable recommendations that emerged. Clinical trial number: not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.